close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Humana (NY:HUM)

281.87 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
These S&P500 stocks that are showing activity before the opening bell on Wednesday.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
Humana Stock Gains On Upbeat Earnings And Raised Guidance, Drawing Retail Praise And UnitedHealth Contrasts
Via Stocktwits
Humana’s (NYSE:HUM) Q2 Sales Beat Estimates, Full-Year Outlook Slightly Exceeds Expectations
Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2025, with sales up 9.6% year on year to $32.39 billion. The company’s full-year revenue guidance of $128... 
Via StockStory
Topics Earnings
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance
From Humana Inc.
Via Business Wire
US Stock Futures Hold Up As Traders Await Meta, Microsoft Earnings — Economists Discount Dovish Fed Ahead Of Rate Decision
Investors may also keep an eye on any developments on the trade news front as President Donald Trump’s Aug. 1 tariff deadline draws closer. 
Via Stocktwits
Topics ETFs Economy Government
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company reported second-quarter results that included a significant cut to its... 
Via StockStory
Topics Lawsuit
Why Repligen (RGEN) Stock Is Up Today
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 7.8% in the morning session after the company reported strong second-quarter 2025 financial results and raised its... 
Via StockStory
Topics Artificial Intelligence Lawsuit
Why Myriad Genetics (MYGN) Shares Are Falling Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the healthcare sector became pronounced following a poor sales report from a key... 
Via StockStory
Topics Artificial Intelligence Lawsuit
Humana (HUM) To Report Earnings Tomorrow: Here Is What To Expect
Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Why Revvity (RVTY) Stock Is Falling Today
Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its full-year profit forecast, which overshadowed its second-quarter earnings and... 
Via StockStory
Topics Lawsuit World Trade
Why QuidelOrtho (QDEL) Shares Are Sliding Today
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company extended a recent losing streak amid investor anxiety ahead of its second-quarter... 
Via StockStory
Topics Lawsuit
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Why Centene (CNC) Stock Is Trading Up Today
Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported second-quarter results that missed earnings estimates, but the stock rallied as... 
Via StockStory
Topics Earnings Lawsuit
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene. 
Via Benzinga
Why Integer Holdings (ITGR) Stock Is Down Today
Shares of medical technology company Integer Holdings (NYSE:ITGR) fell 8.3% in the afternoon session after the company reported second-quarter results that featured a slight miss on a key profitability... 
Via StockStory
Topics Lawsuit
Why Are West Pharmaceutical Services (WST) Shares Soaring Today
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the company reported strong second-quarter 2025 financial results and raised... 
Via StockStory
Topics Lawsuit Supply Chain
Discover Health Group Expands Insurance Network to Improve Access to Addiction Treatment Services
Nashua, New Hampshire--(Newsfile Corp. - July 24, 2025) - Discover Health Group, a trusted rehab center serving New Hampshire, announced... 
Via Newsfile
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory
Topics Lawsuit Stocks World Trade
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was... 
Via StockStory
Topics Lawsuit Stocks World Trade
Thermo Fisher (TMO) Shares Skyrocket, What You Need To Know
Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 12.3% in the afternoon session after the company reported second-quarter earnings and revenue that surpassed Wall Street estimates and... 
Via StockStory
Topics Lawsuit
Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals
Humana will cut prior authorizations, launch a gold card program, and speed up electronic approvals to improve care access and transparency by 2026. 
Via Benzinga
Why Azenta (AZTA) Stock Is Up Today
Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 5.7% in the afternoon session after the investment firm Stephens initiated coverage on the life sciences company. 
Via StockStory
Topics Artificial Intelligence Lawsuit
Why AMN Healthcare Services (AMN) Stock Is Trading Up Today
Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm... 
Via StockStory
Topics Lawsuit
Why Are Fortrea (FTRE) Shares Soaring Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 24.1% in the afternoon session after positive earnings reports from industry peers lifted the entire contract research... 
Via StockStory
Topics Initial Public Offering Lawsuit
Humana To Slash Red Tape Around Prior Authorization For Care Services By 2026: Retail Remains Optimistic
Humana CEO Jim Rechtin said that the current healthcare system is “too complex, frustrating, and difficult to navigate” while emphasising the need to “do better.” 
Via Stocktwits
Humana Accelerates Efforts to Eliminate Prior Authorization Requirements to Ensure a Faster, More Seamless Process
From Humana Inc.
Via Business Wire
Biogen (BIIB) Stock Trades Down, Here Is Why
Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock, citing concerns over the company's growth prospects and high-risk... 
Via StockStory
Topics Lawsuit
Why Molina Healthcare (MOH) Shares Are Sliding Today
Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 3.8% in the afternoon session after TD Cowen lowered its price target on the stock to $283 from $369, citing elevated medical... 
Via StockStory
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today